116 related articles for article (PubMed ID: 36693545)
1. Alginate sulfate-nanoparticles loaded with hepatocyte growth factor and insulin-like growth factor-1 improve left ventricular repair in a porcine model of myocardial ischemia reperfusion injury.
Wu M; Pelacho B; Claus P; De Buck S; Veltman D; Gillijns H; Holemans P; Pokreisz P; Caluwé E; Iglesias Colino E; Cohen S; Prosper F; Janssens S
Eur J Pharm Biopharm; 2023 Mar; 184():83-91. PubMed ID: 36693545
[TBL] [Abstract][Full Text] [Related]
2. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart.
Ellison GM; Torella D; Dellegrottaglie S; Perez-Martinez C; Perez de Prado A; Vicinanza C; Purushothaman S; Galuppo V; Iaconetti C; Waring CD; Smith A; Torella M; Cuellas Ramon C; Gonzalo-Orden JM; Agosti V; Indolfi C; Galiñanes M; Fernandez-Vazquez F; Nadal-Ginard B
J Am Coll Cardiol; 2011 Aug; 58(9):977-86. PubMed ID: 21723061
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
[TBL] [Abstract][Full Text] [Related]
4. Bloodless reperfusion with the oxygen carrier HBOC-201 in acute myocardial infarction: a novel platform for cardioprotective probes delivery.
García-Ruiz JM; Galán-Arriola C; Fernández-Jiménez R; Aguero J; Sánchez-González J; García-Alvarez A; Nuno-Ayala M; Dubé GP; Zafirelis Z; López-Martín GJ; Bernal JA; Lara-Pezzi E; Fuster V; Ibáñez B
Basic Res Cardiol; 2017 Mar; 112(2):17. PubMed ID: 28188434
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary Delivery of Porcine Cardiac Progenitor Cells Overexpressing IGF-1 and HGF in a Pig Model of Sub-Acute Myocardial Infarction.
Prat-Vidal C; Crisóstomo V; Moscoso I; Báez-Díaz C; Blanco-Blázquez V; Gómez-Mauricio G; Albericio G; Aguilar S; Fernández-Santos ME; Fernández-Avilés F; Sánchez-Margallo FM; Bayes-Genis A; Bernad A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685551
[TBL] [Abstract][Full Text] [Related]
6. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
[TBL] [Abstract][Full Text] [Related]
7. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
[TBL] [Abstract][Full Text] [Related]
8. Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart.
Koudstaal S; Bastings MM; Feyen DA; Waring CD; van Slochteren FJ; Dankers PY; Torella D; Sluijter JP; Nadal-Ginard B; Doevendans PA; Ellison GM; Chamuleau SA
J Cardiovasc Transl Res; 2014 Mar; 7(2):232-41. PubMed ID: 24395494
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular magnetic resonance imaging in delivering and evaluating the efficacy of hepatocyte growth factor gene in chronic infarct scar.
Saeed M; Saloner D; Do L; Wilson M; Martin A
Cardiovasc Revasc Med; 2011; 12(2):111-22. PubMed ID: 21421190
[TBL] [Abstract][Full Text] [Related]
10. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
[TBL] [Abstract][Full Text] [Related]
11. Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function.
Yasuda S; Goto Y; Baba T; Satoh T; Sumida H; Miyazaki S; Nonogi H
J Am Coll Cardiol; 2000 Jul; 36(1):115-21. PubMed ID: 10898422
[TBL] [Abstract][Full Text] [Related]
12. Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model.
Gómez-Mauricio G; Moscoso I; Martín-Cancho MF; Crisóstomo V; Prat-Vidal C; Báez-Díaz C; Sánchez-Margallo FM; Bernad A
Stem Cell Res Ther; 2016 Jul; 7(1):94. PubMed ID: 27423905
[TBL] [Abstract][Full Text] [Related]
13. RevaTen platelet-rich plasma improves cardiac function after myocardial injury.
Mishra A; Velotta J; Brinton TJ; Wang X; Chang S; Palmer O; Sheikh A; Chung J; Yang PC; Robbins R; Fischbein M
Cardiovasc Revasc Med; 2011; 12(3):158-163. PubMed ID: 21122486
[TBL] [Abstract][Full Text] [Related]
14. Intra-myocardial injection of both growth factors and heart derived Sca-1+/CD31- cells attenuates post-MI LV remodeling more than does cell transplantation alone: neither intervention enhances functionally significant cardiomyocyte regeneration.
Wang X; Li Q; Hu Q; Suntharalingam P; From AH; Zhang J
PLoS One; 2014; 9(2):e95247. PubMed ID: 24919180
[TBL] [Abstract][Full Text] [Related]
15. The role of cytoprotective cytokines in cardiac ischemia/reperfusion injury.
Anderson CD; Heydarkhan-Hagvall S; Schenke-Layland K; Yang JQ; Jordan MC; Kim JK; Brown DA; Zuk PA; Laks H; Roos KP; Maclellan WR; Beygui RE
J Surg Res; 2008 Aug; 148(2):164-71. PubMed ID: 18067924
[TBL] [Abstract][Full Text] [Related]
16. Nonocclusive multivessel intracoronary infusion of allogeneic cardiosphere-derived cells early after reperfusion prevents remote zone myocyte loss and improves global left ventricular function in swine with myocardial infarction.
Suzuki G; Weil BR; Young RF; Fallavollita JA; Canty JM
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H345-H356. PubMed ID: 31125261
[TBL] [Abstract][Full Text] [Related]
17. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction.
Ruvinov E; Leor J; Cohen S
Biomaterials; 2011 Jan; 32(2):565-78. PubMed ID: 20889201
[TBL] [Abstract][Full Text] [Related]
18. Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).
Caplice NM; DeVoe MC; Choi J; Dahly D; Murphy T; Spitzer E; Van Geuns R; Maher MM; Tuite D; Kerins DM; Ali MT; Kalyar I; Fahy EF; Khider W; Kelly P; Kearney PP; Curtin RJ; O'Shea C; Vaughan CJ; Eustace JA; McFadden EP
Am Heart J; 2018 Jun; 200():110-117. PubMed ID: 29898838
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.
Barlow SC; Doviak H; Jacobs J; Freeburg LA; Perreault PE; Zellars KN; Moreau K; Villacreses CF; Smith S; Khakoo AY; Lee T; Spinale FG
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H690-H699. PubMed ID: 28754718
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory activities of hepatocyte growth factor in post-ischemic heart failure.
Rong SL; Wang XL; Wang YC; Wu H; Zhou XD; Wang ZK; Wang YC; Xue CS; Li B; Gao DL
Acta Pharmacol Sin; 2018 Oct; 39(10):1613-1621. PubMed ID: 29795355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
